ALRN Aileron Therapeutics, Inc. Net earnings per share growth forecast for next year

Corporate company logo of Aileron Therapeutics (ALRN)

Aileron Therapeutics (ALRN) operates as a scientific startup, retaining biochemists through research flexibility and stock options. The forward-looking earnings per share growth forecast confirms this development trajectory, where the -1.10 mark reflects the latest data. The uniqueness of the therapy ensures significant pricing power through patents, while the humanitarian status of biomedicine minimizes any geopolitical risks to the business.

ALRN: Aileron Therapeutics Inc Net earnings per one share growth forecast for next year 07/04/2022 - 11/17/2026

Financial and market metric breakdowns for Aileron Therapeutics Inc (ALRN)

- share price and consensus valuation forecast:
Fundamental company analysis:Aileron, ALRN
Brand item of Aileron Therapeutics, Inc.

Aileron Therapeutics (ALRN) is strengthening its position in oncology through strict adherence to bioethical norms and ESG standards, which minimizes regulatory risks for clinical trials. The expected EPS dynamics for the next period quantify this potential by comparing Wall Street consensus forecasts with internal data, allowing investors to assess the fairness of the current market value and avoid overpaying for inflated earnings expectations.

Competing companies

GMAB (Genmab Corp) - Earnings growth forecast for next year|Earnings growth forecast for next year exelixis.com|Net earnings per share growth forecast for next year Nuvalent (NUVL)|KYMR (Kymera) - Expected earnings per share trend next year|Earnings growth forecast for next year IDYA (IDEAYA Biosciences Inc)|Net earnings per one share growth forecast for next year Enliven Pharma|ORIC Pharmaceuticals Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year Relay Therapeutics, Inc.|NRIX (Nurix Therapeutics) - Expected earnings per share growth for next year|TYRA: Projected earnings per share increase next year|VSTM (verastem.com) - Earnings growth forecast for next year|Expected net earnings per share growth next year Monte Rosa Tx GLUE|Earnings growth forecast for next year CGEM|Immuneering - Projected earnings per share growth rate for next year|C4 Therapeutics - Expected earnings per share growth for next year|Expected earnings per share trend next year BDTX|RPTX: Expected earnings per share growth for next year|PMV Pharma - Projected earnings per share increase next year|KPTI: Earnings growth forecast for next year|Propanc Biopharma Inc. - Expected earnings per share trend next year|BGMS (Cyclacel) - Earnings growth forecast for next year|Expected net earnings per share growth next year aadibio.com AADI|Net earnings per share growth forecast for next year Blueprint Medicines Corp. (BPMC)|GLYC (GlycoMimetics) - Expected earnings per share trend next year|Earnings growth forecast for next year SWTX (SpringWorks Therapeutics, Inc)